Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Shafrin

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Health Economics|April 29, 2009
Operating on commission: analyzing how physician financial incentives affect surgery ratesJason Shafrin
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
When Should You Trust Your Doctor? Establishing a Theoretical Model to Evaluate the Value of Second Opinion VisitsMichael Halasy, Jason Shafrin
JAMA|May 18, 2016
Utility of Cancer Value Frameworks for Patients, Payers, and PhysiciansAmitabh Chandra, Jason Shafrin, Ravinder Dhawan
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
Value Tools in Managed Care Decision Making: Current Hurdles and Future OpportunitiesJeremy Schafer, Dominic Galante, Jason Shafrin
Journal of Comparative Effectiveness Research|May 21, 2024
Cost-effectiveness of sotagliflozin for the treatment of patients with diabetes and recent worsening heart failureJaehong Kim, Shanshan Wang, Slaven Sikirica, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 30, 2023
A Decade of Health Innovation: The Impact of New Medicines on Patient Health and the Implications for NICE's Size of Benefit MultiplierJason Shafrin, Sabiha Quddus, Moises Marin, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2025
Economic impact of sotagliflozin among patients with heart failure and type 2 diabetes: Budget impact analysis from the US payer perspectiveJason Shafrin, Shanshan Wang, Jaehong Kim, et al.
BMJ Open|November 17, 2024
Health economic value of postacute oral nutritional supplementation in older adult medical patients at risk for malnutrition: a US-based modelling approachShanshan Wang, Jason Shafrin, Kirk W Kerr, et al.
The American Journal of Managed Care|June 23, 2025
Factors that increase utilization management risk: a proof of conceptJason Shafrin, Jacob Fajnor, Shurui Zhang, et al.
Plos One|August 23, 2017
The association between observed mobility and quality of life in the near elderlyJason Shafrin, Jeff Sullivan, Dana P Goldman, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Health Economics|April 29, 2009
Operating on commission: analyzing how physician financial incentives affect surgery ratesJason Shafrin
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
When Should You Trust Your Doctor? Establishing a Theoretical Model to Evaluate the Value of Second Opinion VisitsMichael Halasy, Jason Shafrin
JAMA|May 18, 2016
Utility of Cancer Value Frameworks for Patients, Payers, and PhysiciansAmitabh Chandra, Jason Shafrin, Ravinder Dhawan
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
Value Tools in Managed Care Decision Making: Current Hurdles and Future OpportunitiesJeremy Schafer, Dominic Galante, Jason Shafrin
Journal of Comparative Effectiveness Research|May 21, 2024
Cost-effectiveness of sotagliflozin for the treatment of patients with diabetes and recent worsening heart failureJaehong Kim, Shanshan Wang, Slaven Sikirica, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 30, 2023
A Decade of Health Innovation: The Impact of New Medicines on Patient Health and the Implications for NICE's Size of Benefit MultiplierJason Shafrin, Sabiha Quddus, Moises Marin, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2025
Economic impact of sotagliflozin among patients with heart failure and type 2 diabetes: Budget impact analysis from the US payer perspectiveJason Shafrin, Shanshan Wang, Jaehong Kim, et al.
BMJ Open|November 17, 2024
Health economic value of postacute oral nutritional supplementation in older adult medical patients at risk for malnutrition: a US-based modelling approachShanshan Wang, Jason Shafrin, Kirk W Kerr, et al.
The American Journal of Managed Care|June 23, 2025
Factors that increase utilization management risk: a proof of conceptJason Shafrin, Jacob Fajnor, Shurui Zhang, et al.
Plos One|August 23, 2017
The association between observed mobility and quality of life in the near elderlyJason Shafrin, Jeff Sullivan, Dana P Goldman, et al.
Pageof 9